EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 200 filers reported holding EDITAS MEDICINE INC in Q3 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $741 | -5.2% | 95 | 0.0% | 0.00% | – |
| Q2 2023 | $782 | +13.5% | 95 | 0.0% | 0.00% | – |
| Q1 2023 | $689 | -18.3% | 95 | 0.0% | 0.00% | – |
| Q4 2022 | $843 | -15.7% | 95 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -83.3% | 95 | -82.6% | 0.00% | -100.0% |
| Q2 2022 | $6,000 | -25.0% | 545 | +31.3% | 0.00% | – |
| Q1 2022 | $8,000 | -27.3% | 415 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $11,000 | -35.3% | 415 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $17,000 | +750.0% | 415 | +1283.3% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 30 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -75.0% | 30 | -80.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 150 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 150 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $5,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $5,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |